Hetero Labs Profile
Key Indicators
- Authorised Capital ₹ 320.00 Cr
as on 31-12-2024
- Paid Up Capital ₹ 277.06 Cr
as on 31-12-2024
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5,716.35 Cr
as on 31-12-2024
- Satisfied Charges ₹ 13,849.42 Cr
as on 31-12-2024
- Revenue 10.43%
(FY 2023)
- Profit 10.80%
(FY 2023)
- Ebitda 21.70%
(FY 2023)
- Net Worth 12.37%
(FY 2023)
- Total Assets 10.59%
(FY 2023)
About Hetero Labs
The Corporate was formerly known as Permila Drugs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 320.00 Cr and a paid-up capital of Rs 277.06 Cr.
The company currently has active open charges totaling ₹5,716.35 Cr. The company has closed loans amounting to ₹13,849.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hetero Labs Limited India are Sudershan Pallap as COMPANY SECRETARY and Bhavesh Pujara as Cfo. Bandi Vamsikrishna, Govindaraju Bhavani, Sujesh Vasudevan, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24110TG1989PLC009723
- Company No.
009723
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hetero Labs Limited offer?
Hetero Labs Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Remdesivir Injection, Anti Cancer Injection, Bevacizumab, Favipiravir Tablet, Favivir Tablet, Pain Reliever Gel, Combiflam Gel, Paracetamol Tablets, Combiflam Tablet.
Who are the key members and board of directors at Hetero Labs?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bandi Vamsikrishna  | Managing Director | 10-Apr-2008 | Current |
| Sudershan Pallap | Company Secretary | 01-Apr-2021 | Current |
| Bhavesh Pujara | CFO | 17-Nov-2022 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Govindaraju Bhavani | Director | 11-Aug-2023 | Current |
| Sujesh Vasudevan | Director | 22-Feb-2024 | Current |
| Rathnakar Kura | Director | 02-Jun-2014 | Current |
| Mohana Chilukuri | Whole-Time Director | 18-Nov-1999 | Current |
| Attunuri Reddy | Whole-Time Director | 02-Jun-2014 | Current |
| Srinivas Male | Director | 25-Sep-2008 | Current |
Financial Performance of Hetero Labs.
Hetero Labs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.43% increase. The company also saw a substantial improvement in profitability, with a 10.8% increase in profit. The company's net worth Soared by an impressive increase of 12.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hetero Labs?
In 2023, Hetero Labs had a promoter holding of 100.00%. The company had 14 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hetero Marbles Private LimitedActive 27 years 7 monthsBandi Vamsikrishna and Srinivas Male are mutual person
Hetero Drugs LimitedActive 31 years 9 monthsBandi Vamsikrishna, Rathnakar Kura and 2 more are mutual person
- Hetero Biopharma LimitedActive 8 years 4 months
Bandi Vamsikrishna, Govindaraju Bhavani and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Jul 2024 | ₹1.50 M | Open |
Others Creation Date: 13 Jul 2024 | ₹1.48 M | Open |
Others Creation Date: 28 Jun 2024 | ₹0.90 M | Open |
How Many Employees Work at Hetero Labs?
Hetero Labs has a workforce of 7319 employees as of Nov 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hetero Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
